Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Luvo and Ryk inspire UFS student leaders
2017-10-13

 Description: Luvo  and Ryk  Tags: Luvo Manyonga, Ryk Neethling, IAAF World Championships, World Champion, Khomotso Mamburu 

 Ryk Neethling and Luvo Manyonga have a special bond.
 The sporting duo shared their inspiring stories with student
 Leaders of the University of the Free State.
 Photo: Kaleidoscope Studios


Dreams can come true and Luvo Manyonga’s story is the perfect example. It would make the ideal movie script. This is opinion of the businessman and former international swimmer Ryk Neethling.
 
The Olympic gold medallist and former World Champion and Manyonga shared their stories with new student leaders of the University of the Free State (UFS).

“I am so proud of this guy,” Neethling said. “And we are just half-way through this movie. The best is yet to come.” The 26-year-old Manyonga is the current Olympic silver medallist and World Champion in long jump. But he had to overcome huge obstacles as a former tik or crystal meth addict.

Not an easy road
The duo were guests for a session, Inspirational Stories of Lived Humanising Experiences, which was part of the university’s Student Leadership Training weekend for Student Representative Councils, Residence committees, Residence Assistants and Association Representatives in the Economic and Management Sciences Auditorium on the Bloemfontein Campus.

Manyonga, who is dating the Kovsie netball player Khomotso Mamburu, talked about growing up in Mbekweni township in Paarl, about his career and his setbacks.

After finishing fifth at the IAAF World Championships in Daegu, South Korea, in 2011 he started partying when he returned home. “I hooked up with the wrong friends and they introduced me to tik,” he said. “They told me: ‘Hey dude, you are drunk. Just take a hit and it will sober you up.’ I took it and it was nice, but that is where it started.”

Be surrounded by positive people  
Manyonga lost all his money and his sport was also suffering because of his addiction. “At the beginning of 2014 I started to realise that I was throwing my life away and I needed help. I went to reach out to people close to me and told them I had a problem.” He thanked Neethling, who helped him when he was at his lowest, his mother, the South African Sports Confederation and Olympic Committee, Tuks Sport and the High Performance Centre where he trains for the influence on his life.

Neethling’s advice to student leaders was to dream big, work hard, expand your network and find a mentor you can learn from.

“Always surround yourself with positive people,” he said. “You can succeed if you stay positive.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept